Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-13-013257
Filing Date
2013-03-06
Accepted
2013-03-06 16:25:23
Documents
1
Period of Report
2013-03-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v337261_4.html 4  
1 OWNERSHIP DOCUMENT v337261_4.xml 4 3694
  Complete submission text file 0001144204-13-013257.txt   5359
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Issuer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 28 TUDOR ROSE TERRACE MAHWAH NJ 07430
Business Address
Tarriff Scott (Reporting) CIK: 0001469124 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12584 | Film No.: 13669854